Given the increasing clinical use of calcimimetics in the treatment of hyperparathyroidism and the potential for using calcilytics in the treatment of osteoporosis, it is essential to understand the role of CaR in cardiac function [29]. This evidence concerns the gene CASR and hyperparathyroidism.